Save your place

Sign in to WhoBought

Please try again later.

Revolution Medicines, Inc. (RVMD) institutional ownership

Latest close $188.07 Jul 27, 2026
Market cap$32.7B 52-week range SectorHealthcare
Funds holding · Q1 2026
486
reported RVMD position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $91M
326 buyers · 160 sellers

Revolution Medicines, Inc. (RVMD) price and institutional activity

Dates

Q1 2026

$3.2B bought by 326 investors
Adage Capital Partners Gp, L.L.C.$330MBlackRock$231M +324 more
$3.2B sold by 160 investors
Bellevue Group AG-$350MJanus Henderson Group PLC-$256M +158 more
Bought Sold Totals per quarter; hover a bar for the names.

Revolution Medicines, Inc. (RVMD) institutional activity · 486

Investor Type Est. change Change Δ Own Date
Bellevue Group AG · Reduced −$350M
Change −3.5M Date Q1 2026
Bellevue Group AG Reduced· Q1 2026 −$350M −3.5M Q1 2026
Adage Capital Partners Gp, L.L.C. · Added +$330M
Change +3.3M Date Q1 2026
Adage Capital Partners Gp, L.L.C. Added· Q1 2026 +$330M +3.3M Q1 2026
Janus Henderson Group PLC · Reduced −$256M
Change −2.5M Date Q1 2026
Janus Henderson Group PLC Reduced· Q1 2026 −$256M −2.5M Q1 2026
Norges · Exited −$248M
Change −2.5M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$248M −2.5M −100.0% Q1 2026
BlackRock · Added +$231M
Change +2.3M Date Q1 2026
BlackRock Added· Q1 2026 +$231M +2.3M Q1 2026
Darwin Global Management, Ltd. · New +$223M
Change +2.2M Date Q1 2026
Darwin Global Management, Ltd. New· Q1 2026 +$223M +2.2M Q1 2026
General Atlantic, L.P. · Reduced −$213M
Change −2.1M Date Q1 2026
General Atlantic, L.P. Reduced· Q1 2026 −$213M −2.1M Q1 2026
Vestal Point Capital, LP · Added +$210M
Change +2.1M Date Q1 2026
Vestal Point Capital, LP Added· Q1 2026 +$210M +2.1M Q1 2026
National Bank of Canada · New +$177M
Change +1.7M Date Q1 2026
National Bank of Canada New· Q1 2026 +$177M +1.7M Q1 2026
Abu Dhabi Investment Council Co P.j.s.c · New +$176M
Change +1.7M Date Q1 2026
Abu Dhabi Investment Council Co P.j.s.c New· Q1 2026 +$176M +1.7M Q1 2026
Lunate Capital Ltd · Reduced −$166M
Change −1.6M Date Q1 2026
Lunate Capital Ltd Reduced· Q1 2026 −$166M −1.6M Q1 2026
Alyeska Investment Group, L.P. · Added +$166M
Change +1.6M Date Q1 2026
Alyeska Investment Group, L.P. Added· Q1 2026 +$166M +1.6M Q1 2026
T. Rowe Price Investment Management, Inc. · Reduced −$155M
Change −1.5M Date Q1 2026
T. Rowe Price Investment Management, Inc. Reduced· Q1 2026 −$155M −1.5M Q1 2026
UBS Group AG · Added +$131M
Change +1.3M Date Q1 2026
UBS Group AG Added· Q1 2026 +$131M +1.3M Q1 2026
Westfield Capital Management Co LP · Reduced −$130M
Change −1.3M Date Q1 2026
Westfield Capital Management Co LP Reduced· Q1 2026 −$130M −1.3M Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 486

Famous investor activity in Revolution Medicines, Inc. (RVMD)

Revolution Medicines, Inc. (RVMD) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Patel Sushil · Director 9 operations −$1.0M
Price $183.17–$192.61 Qty −6K Owned 22K ΔOwn −20.5% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Patel Sushil Director 9 operations $183.17–$192.61 −6K −$1.0M 22K −20.5% Jun 29, 2026 Jul 1, 2026
Patel Sushil · Director 2 operations 0
Price $37.54 Owned 13K Trade date Jun 29, 2026 Filed date Jul 1, 2026
Patel Sushil Director 2 operations $37.54 0 13K Jun 29, 2026 Jul 1, 2026
Anders Jack · Officer 4 operations −$3.4M
Price $167.34–$170.32 Qty −20K Owned 123K ΔOwn −14.0% Trade date Jun 24, 2026 Filed date Jun 26, 2026
Anders Jack Officer 4 operations $167.34–$170.32 −20K −$3.4M 123K −14.0% Jun 24, 2026 Jun 26, 2026
Anders Jack · Officer 2 operations 40K
Price $18.56 Owned 21K Trade date Jun 24, 2026 Filed date Jun 26, 2026
Anders Jack Officer 2 operations $18.56 40K 21K Jun 24, 2026 Jun 26, 2026
Kim Lorence H. · Director 2 operations 4K
Owned 3K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Kim Lorence H. Director 2 operations 4K 3K Jun 18, 2026 Jun 23, 2026
Borisy Alexis · Director 2 operations 4K
Owned 3K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Borisy Alexis Director 2 operations 4K 3K Jun 18, 2026 Jun 23, 2026
Anderson Elizabeth M. · Director 2 operations 4K
Owned 3K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Anderson Elizabeth M. Director 2 operations 4K 3K Jun 18, 2026 Jun 23, 2026
Horning Sandra · Director 2 operations 4K
Owned 3K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Horning Sandra Director 2 operations 4K 3K Jun 18, 2026 Jun 23, 2026
Clyburn Frank · Director 2 operations 4K
Owned 3K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Clyburn Frank Director 2 operations 4K 3K Jun 18, 2026 Jun 23, 2026
Patel Sushil · Director 2 operations 4K
Owned 3K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Patel Sushil Director 2 operations 4K 3K Jun 18, 2026 Jun 23, 2026
Borellini Flavia · Director 2 operations 4K
Owned 3K Trade date Jun 18, 2026 Filed date Jun 23, 2026
Borellini Flavia Director 2 operations 4K 3K Jun 18, 2026 Jun 23, 2026
Horn Margaret A. · Officer Sell −$4.7M
Price $160.12 Qty −30K Owned 155K Trade date Jun 17, 2026 Filed date Jun 17, 2026
Horn Margaret A. Officer Sell $160.12 −30K −$4.7M 155K Jun 17, 2026 Jun 17, 2026
Horn Margaret A. · Officer 6 operations 0
Price $26.50–$40.74 Owned 114K Trade date Jun 17, 2026 Filed date Jun 17, 2026
Horn Margaret A. Officer 6 operations $26.50–$40.74 0 114K Jun 17, 2026 Jun 17, 2026
Mancini Anthony · Officer Sell −$720K
Price $156.12 Qty −5K Owned 50K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Mancini Anthony Officer Sell $156.12 −5K −$720K 50K Jun 16, 2026 Jun 18, 2026
Goldsmith Mark A. · Director Sell −$1.6M
Price $156.12 Qty −10K Owned 267K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Goldsmith Mark A. Director Sell $156.12 −10K −$1.6M 267K Jun 16, 2026 Jun 18, 2026
15 of 96
15 of 96 Sign in to continue to older insider transactions.

Revolution Medicines, Inc. (RVMD) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 14.6M
% of shares outstanding 8.9% Filing date Feb 13, 2024
Vanguard Group Inc 14.6M 8.9% Feb 13, 2024
BlackRock Inc. 13.0M
% of shares outstanding 7.9% Filing date Jan 26, 2024
BlackRock Inc. 13.0M 7.9% Jan 26, 2024
Wellington Management Group LLP 11.4M
% of shares outstanding 6.8% Filing date Nov 8, 2024
Wellington Management Group LLP 11.4M 6.8% Nov 8, 2024
Janus Henderson Group PLC 9.8M
% of shares outstanding 4.9% Filing date May 15, 2026
Janus Henderson Group PLC 9.8M 4.9% May 15, 2026
Biotechnology Value Fund L P 4.6M
% of shares outstanding 4.4% Filing date Jun 30, 2023
Biotechnology Value Fund L P 4.6M 4.4% Jun 30, 2023
Bb Biotech AG 5.0M
% of shares outstanding 3.1% Filing date Feb 13, 2024
Bb Biotech AG 5.0M 3.1% Feb 13, 2024
Farallon Capital Partners, L.P. 3.3M
% of shares outstanding 3.0% Filing date Feb 12, 2024
Farallon Capital Partners, L.P. 3.3M 3.0% Feb 12, 2024
Third Rock Ventures Iii, L.P. 1.6M
% of shares outstanding 1.8% Filing date Feb 14, 2023
Third Rock Ventures Iii, L.P. 1.6M 1.8% Feb 14, 2023
8 of 11

Revolution Medicines, Inc. (RVMD) ownership FAQ

Who owns RVMD?

486 reporting institutions disclosed RVMD position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.